Improvement of renal function and disapp
โ
Maria Grazia Anelli; Diletta Domenica Torres; Carlo Manno; Crescenzio Scioscia;
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 38 KB
๐ 2 views
Reactive systemic AA amyloidosis is a severe complication of rheumatoid arthritis (RA), occurring in 2-5% of RA patients (1). Infliximab, a monoclonal antibody against tumor necrosis factor โฃ (TNFโฃ), is successfully used in the treatment of RA (2). TNFโฃ plays a key role in inducing the synthesis of